Telecom Signaling Industry News

TMCNet:  Research and Markets: Acute Pain - Pipeline Review, H1 2014

[June 11, 2014]

Research and Markets: Acute Pain - Pipeline Review, H1 2014

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Acute Pain - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Acute Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Pain and special features on late-stage and discontinued projects.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set ofinformation. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


  • The report provides a snapshot of the global therapeutic landscape of Acute Pain
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Acute Pain and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects

Companies Mentioned:

  • Nektar Therapeutics
  • Santen Pharmaceutical Co., Ltd.
  • Pacira Pharmaceuticals, Inc.
  • AcelRx Pharmaceuticals, Inc.
  • Laboratorios Del Dr. Esteve S.A.
  • Pfizer Inc.
  • Sigma-Tau S.p.A.
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Anavex Life Sciences Corp.
  • Nuvo Research Inc.
  • Zalicus Inc.
  • Yungjin Pharm Ind. Co., Ltd.
  • Array BioPharma Inc.
  • Orexo AB
  • Insys Therapeutics, Inc.
  • Grunenthal GmbH
  • AngioChem Inc.
  • Charleston Laboratories, Inc.
  • Trevena, Inc.
  • Syntrix Biosystems, Inc.
  • Kineta, Inc.
  • QRxPharma Limited
  • Cara Therapeutics, Inc.
  • Iroko Pharmaceuticals, LLC
  • Encore Therapeutics Inc.
  • Madeira Therapeutics

For more information visit

[ Back To Telecom Signaling's Homepage ]

Featured Events

5G NA Signaling Day

November 14-16, 2016
Sheraton Dallas, Dallas, TX

Featured Webcasts

Securing The Signaling Interconnect: Oracle's Perspective On Recent Security Events

Today's telecommunications landscape is changing rapidly, and the "institution" of trust between networks that has been assumed over the decades is no longer relevant. We are now hearing of vulnerabilities in CSP interconnection points that have been known ...

Applications of Wi-Fi Calling

With all of the discussion about faster data access and richer content, it could be assumed that voice services no longer play an important role in the business model of the communications service provider. Join ReThink Technologies Research and Oracle Communications as we explore ...

Featured Whitepapers

Oracle Communications Diameter Signaling Router Main Differentiators

Diameter is the protocol used by network elements in LTE and 3G networks to enable and monetize services, such as voice, video and data. Diameter enables revenue-generating data services; including tiered data plans, loyalty programs, application specific QoS, content provider and Internet of Things (IoT) solutions ...

Multi-Layer Security Protection for Signaling Networks

The sanctity of mobile operators' networks and brands will depend greatly on their ability to deliver QoS guarantees to roaming and interconnect partners, while simultaneously protecting increasingly multimedia-savvy and socially connected ...

Featured Datasheets

Oracle Communications Diameter Signaling Router

Centralizing Diameter routing with cloud deployable Oracle Communications Diameter Signaling Router creates a secure signaling architecture that reduces the cost and complexity of the core network and enables elastic growth, interoperability and rapid introduction ...

Oracle Communications Mobile Security Gateway

The Oracle Communications Mobile Security Gateway is a high performance gateway that allows the Communications Service Provider (CSP) to cost effectively expand network coverage and increase capacity by incorporating Heterogeneous ...

Oracle Communications Evolved Communications Application Server

As service providers drive their networks toward an all-IP and virtualized state, they require the means to design and deliver compelling high definition voice, video and multimedia offers via Voice over LTE (VoLTE) and Voice over WiFi (VoWiFi) ...

Featured Infographic